The effect of NR4A1 on APP metabolism and tau phosphorylation

Alzheimer's disease (AD) is characterized by senile plaques (SP) composed of β-amyloid protein (Aβ) and neurofibrillary tangles (NFTs) composed of intracellular hyperphosphorylated tau. Recently, nuclear receptor subfamily 4 group A member 1 (NR4A1) was implicated in synaptic plasticity, long-term memory formation, suggesting that it may play a role in the pathophysiology of AD. Here, we showed that the expression of NR4A1 was significantly increased in the hippocampus of APP/PS1 transgenic mice. In addition, NR4A1 overexpression in HT22 cells up-regulated APP and BACE1 levels, down-regulated ADAM10 expression, and promoted amyloidogenesis as indicated by decreased α-CTF levels and elevated β-CTF levels. Furthermore, a raised level of phospho-tau (p-tau, S396) was accompanied by p-GSK3β (S9) expression reducing, but total tau, p-tau (S262 and T231), CDK5 and ERK remained unchanged in NR4A1-overexpressing cells. Collectively, our results suggest that NR4A1 promotes the amyloidogenic processing of APP by regulating ADAM10 and BACE1 expression in HT22 cells; as well as NR4A1 accelerates tau hyperphosphorylation by GSK3β signal. Therefore, NR4A1 may play an important role in the pathogenesis of AD.

[1]  M. Pallàs,et al.  Kainate induces AKT, ERK and cdk5/GSK3β pathway deregulation, phosphorylates tau protein in mouse hippocampus , 2007, Neurochemistry International.

[2]  P. Wong,et al.  The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential , 2009, The Journal of Neuroscience.

[3]  Ling He,et al.  Histone deacetylase inhibitor apicidin increases expression of the α‐secretase ADAM10 through transcription factor USF1‐mediated mechanisms , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  A. Sanabria-Castro,et al.  Molecular Pathogenesis of Alzheimer's Disease: An Update , 2017, Annals of Neurosciences.

[5]  D. Knopman,et al.  Alzheimer Disease: Scientific Breakthroughs and Translational Challenges , 2017, Mayo Clinic proceedings.

[6]  T. Abel,et al.  Pharmacological Activators of the NR4A Nuclear Receptors Enhance LTP in a CREB/CBP-Dependent Manner , 2017, Neuropsychopharmacology.

[7]  T. Abel,et al.  The role of NR4A transcription factors in memory formation , 2011, Brain Research Bulletin.

[8]  K. Imahori,et al.  Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. , 1997, Journal of biochemistry.

[9]  M. Billingsley,et al.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. , 1997, The Biochemical journal.

[10]  Zhen Yan,et al.  Chronic nicotine differentially affects murine transcriptome profiling in isolated cortical interneurons and pyramidal neurons , 2017, BMC Genomics.

[11]  K. Giese,et al.  Frontiers in Molecular Neuroscience Molecular Neuroscience Review Article Crosstalk between Cdk5 and Gsk3β: Implications for Alzheimer's Disease Co-localization and Mutual Regulation of Gsk3β and Cdk5 , 2022 .

[12]  P. Jeffrey,et al.  Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo. , 2007, Journal of neurochemistry.

[13]  P. Manzine,et al.  Correlation between mini-mental state examination and platelet ADAM10 expression in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[14]  P. Agostinho,et al.  Localization and Trafficking of Amyloid-β Protein Precursor and Secretases: Impact on Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.

[15]  D. Leotta,et al.  Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson’s and Alzheimer’s Disease Patients , 2016, Neurotoxicity Research.

[16]  Bradley T. Hyman,et al.  Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease , 2014, Acta Neuropathologica.

[17]  P. Saftig,et al.  The alpha secretase ADAM10: A metalloprotease with multiple functions in the brain , 2015, Progress in Neurobiology.

[18]  H. Hampel,et al.  Beta‐site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease , 2009, Scandinavian journal of clinical and laboratory investigation.

[19]  P. Neumeister,et al.  The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. , 2015, Current drug targets.

[20]  H. Ranhotra.  The NR4A orphan nuclear receptors: mediators in metabolism and diseases , 2015, Journal of receptor and signal transduction research.

[21]  E. Masliah,et al.  Molecular mechanisms of neurodegeneration in Alzheimer's disease. , 2010, Human molecular genetics.

[22]  N. Seidah,et al.  Coordinated Expression of β‐Amyloid Precursor Protein and the Putative β‐Secretase BACE and α‐Secretase ADAM10 in Mouse and Human Brain , 2000 .

[23]  E. Hol,et al.  ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects , 2015, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[24]  K. Wang,et al.  Therapeutic approaches to Alzheimer's disease through stimulating of non-amyloidogenic processing of amyloid precursor protein. , 2016, European review for medical and pharmacological sciences.

[25]  P. Jeffrey,et al.  Oral administration of a potent and selective non‐peptidic BACE‐1 inhibitor decreases β‐cleavage of amyloid precursor protein and amyloid‐β production in vivo , 2007 .

[26]  F. LaFerla,et al.  Alzheimer's disease. , 2010, The New England journal of medicine.

[27]  M. Vázquez-Carrera,et al.  The NR4A subfamily of nuclear receptors: potential new therapeutic targets for the treatment of inflammatory diseases , 2017, Expert opinion on therapeutic targets.

[28]  T. Abel,et al.  The NR4A orphan nuclear receptors mediate transcription-dependent hippocampal synaptic plasticity , 2013, Neurobiology of Learning and Memory.